Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Vilin Bio Med Ltd Fundamentals

Market Cap
₹ 27.9 Cr
P/E Ratio (TTM)
166.67
P/B Ratio
1.22
Debt to Equity
0.57
ROE
EPS (TTM)
0.12
Dividend Yield
0.00 %
Book Value
16.37

Click here to know more about Fundamentals

Vilin Bio Med Ltd Financials

Vilin Bio Med Ltd Financials

Vilin Bio Med Ltd Shareholding Pattern

Held By Mar 2024 Sep 2023 Jun 2023 Jun 2023
Promoters 64.52 % 64.52 % 90.45 % 64.52 %
Retail 33.84 % 32.80 % 9.45 % 32.55 %
Others 1.64 % 2.68 % 0.10 % 2.93 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %
FII 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

64.52%

Retail

33.84%

Others

1.64%

Mutual Funds

0.00%

FII

0.00%

Promoters

64.52%

Retail

32.80%

Others

2.68%

Mutual Funds

0.00%

FII

0.00%

Promoters

90.45%

Retail

9.45%

Others

0.10%

Mutual Funds

0.00%

FII

0.00%

Promoters

64.52%

Retail

32.55%

Others

2.93%

Mutual Funds

0.00%

FII

0.00%

Resistance and Support

₹20.00

PIVOT

resistance-arrow
Resistance
First Resistance₹20.000
Second Resistance₹20.000
Third Resistance₹20.000
support-arrow
Support
First Support₹20.000
Second Support₹20.000
Third Support₹20.000

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day4,0004,000100.00
Week4,0004,8000.00
1 Month4,00010,6670.00
6 Months2,464,0002,072,00088.93

About Vilin Bio Med Ltd

Vilin Bio Med Limited was originally incorporated as a public limited company dated June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. In order to maintain competitiveness and to further the cause of Healthcare, Company has laid a R&D Foundation and state of the art Manufacturing Facility in Roorkee. The major products for manufacturing dosage forms consist of Oral Liquid (Syrups/Suspensions/Dry Powders (ßeta & Non ßeta-Lactam), Tablets & Capsules (ßeta & Non ßeta-Lactam) and External Preparations. Ointments along with similar products like Creams, Lotions, Gels or Pates are certain formulations primarily designed to be applied to the skin. Beta-Lactam are a group of medicines that are used to treat infections caused by some germs (bacteria and certain parasites). They do not work against infections that are caused by viruses - for example, the common cold or flu. There are various type of dosages in this group like Tablets, Capsules, Injection and Dry Syrups for Oral Solution. Non-Beta-Lactam Tablets & Capsule Products group medicines are generally used for general diseases like Cold, Flu, Fever, Anti-gastrological, Antimalaria,and several other viral diseases. Antibiotics are normally only prescribed for more serious bacterial infections, as many infections get better on their own. The Company is proposing to issue size aggregating to Rs 12 crores by issuing 40,00,000 equity shares through Fresh Issue to the Public.

Managing Director

S Viswa Prasad

Founded

2005

NSE Symbol

VILINBIO

Vilin Bio Med Ltd Management

NameDesignation
Veerareddy VallapureddyIndependent Director
Rakesh Kumar ChandakIndependent Director
S Viswa PrasadManaging Director
Anuj BajpaiWhole-time Director
S Padmaja KalyaniNon Executive Director
Ashdeep KaurCompany Sec. & Compli. Officer

Vilin Bio Med Ltd News

Vilin Bio Med to table results
On 29 May 2024
Vilin Bio Med to discuss results
On 8 February 2024
Vilin Bio Med to discuss results
On 10 November 2023
Vilin Bio Med to conduct AGM
On 23 September 2023
Vilin Bio Med announces board meeting date
On 24 August 2023
Vilin Bio Med to table results
On 19 July 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
Sun Pharmaceuticals Industries Ltd₹ 360859.98 Cr
₹ 1,477.15
(-1.79 %)
118.72
Cipla Ltd₹ 125945.39 Cr
₹ 1,541.40
(-1.18 %)
33.90
Divis Laboratories Ltd₹ 118921.96 Cr
₹ 4,461.50
(-0.41 %)
75.42
Zydus Lifesciences Ltd₹ 108024.25 Cr
₹ 1,066.05
(-0.70 %)
31.33
Dr Reddys Laboratories Ltd₹ 99363.93 Cr
₹ 5,955.55
(-0.01 %)
22.88

Vilin Bio Med Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Vilin Bio Med Ltd shares in BlinkX

Vilin Bio Med Ltd's P/E ratio is 166.67 times as of June 19, 2024 at 04:00 PM.

Vilin Bio Med Ltd's most recent financial reports indicate a price-to-book ratio of 1.22, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Vilin Bio Med Ltd's market is 28 Cr as on June 19, 2024 at 04:00 PM.

The current financial records of Vilin Bio Med Ltd show a % ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

According to Vilin Bio Med Ltd's most recent financial filings, the company has a total asset value of Crores, which includes current and non-current assets such as inventory, cash, properties, and equipment.

As of the Mar 2024 quarter, the promoter shareholding in Vilin Bio Med Ltd stands at 64.52%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.